Kyrgyzstan vs Malaysia: Cause of death, by non-communicable diseases, ages 5-14
Kyrgyzstan
36.0%
in 2021
Malaysia
37.3%
in 2021
Kyrgyzstan rank
100th
Malaysia rank
98th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Kyrgyzstan
- Malaysia
How they compare
Malaysia currently reports 37.3% against 36.0% in Kyrgyzstan, a difference of 1.3%.
Across all 6 years both countries report, Malaysia has been ahead every year.
Kyrgyzstan ranks 100th and Malaysia ranks 98th of 185 countries.
Malaysia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kyrgyzstan | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 28.5% | 39.3% | 10.8% | Malaysia |
| 2010s | 35.7% | 43.3% | 7.6% | Malaysia |
| 2020s | 36.1% | 42.4% | 6.3% | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Kyrgyzstan or Malaysia?
- Malaysia, at 37.3% against 36.0% in Kyrgyzstan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Kyrgyzstan and Malaysia?
- 1.3%, with Malaysia ahead.
- How many years of comparable data are there for Kyrgyzstan and Malaysia?
- 6 years are reported by both, from 2000 to 2021.
- How do Kyrgyzstan and Malaysia rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Kyrgyzstan ranks 100th and Malaysia ranks 98th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.